Process View
A change in morphology and behavior of a lymphocyte resulting from exposure to a specific antigen, mitogen, cytokine, chemokine, cellular ligand, or soluble factor, leading to the initiation or perpetuation of an immune response.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "lymphocyte activation involved in immune response"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 0.950 | ||
| FHL2 | four and a half LIM domains 2 | 0.854 | ||
| IL4R | interleukin 4 receptor | 0.424 | Mouse | |
| PTPN6 | protein tyrosine phosphatase, non-receptor type 6 | 0.330 | ||
| LILRA6 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6 | 0.232 | ||
| PILRA | paired immunoglobin-like type 2 receptor alpha | 0.228 | ||
| GRAP2 | GRB2-related adaptor protein 2 | 0.166 | ||
| LILRB2 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 | 0.151 | Human | |
| HLA-DMA | major histocompatibility complex, class II, DM alpha | 0.150 | ||
| LILRB1 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 | 0.149 | ||
| MDC1 | mediator of DNA-damage checkpoint 1 | 0.137 | ||
| RELB | v-rel reticuloendotheliosis viral oncogene homolog B | 0.132 | Mouse | |
| NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 0.127 | ||
| APLF | aprataxin and PNKP like factor | 0.123 | ||
| ENG | endoglin | 0.112 | ||
| LILRB3 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3 | 0.107 | Human | |
| ITGAL | integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) | 0.097 | ||
| NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 0.095 | ||
| RXRA | retinoid X receptor, alpha | 0.088 | ||
| BRCA1 | breast cancer 1, early onset | 0.085 | ||
| ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.085 | ||
| LIN9 | lin-9 homolog (C. elegans) | 0.081 | ||
| TGIF1 | TGFB-induced factor homeobox 1 | 0.076 | ||
| H2AFX | H2A histone family, member X | 0.076 | ||
| NR0B1 | nuclear receptor subfamily 0, group B, member 1 | 0.069 | ||
| BIRC3 | baculoviral IAP repeat containing 3 | 0.066 | ||
| NKX2-5 | NK2 transcription factor related, locus 5 (Drosophila) | 0.064 | ||
| FLNA | filamin A, alpha | 0.060 | ||
| CALCOCO2 | calcium binding and coiled-coil domain 2 | 0.058 | ||
| MSH6 | mutS homolog 6 (E. coli) | 0.057 | Mouse | |
| IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) | 0.056 | ||
| THOC5 | THO complex 5 | 0.055 | ||
| SIGLEC7 | sialic acid binding Ig-like lectin 7 | 0.050 | ||
| NFKBIE | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 0.048 | ||
| CD22 | CD22 molecule | 0.048 | ||
| PTPRC | protein tyrosine phosphatase, receptor type, C | 0.047 | Mouse | |
| PECAM1 | platelet/endothelial cell adhesion molecule | 0.047 | ||
| STAT6 | signal transducer and activator of transcription 6, interleukin-4 induced | 0.046 | Mouse | |
| THOC4 | THO complex 4 | 0.045 | ||
| IL23A | interleukin 23, alpha subunit p19 | 0.043 | Mouse | |
| ITGB2 | integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) | 0.043 | ||
| LILRA1 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 1 | 0.040 | Human | |
| ESR1 | estrogen receptor 1 | 0.039 | ||
| LIG4 | ligase IV, DNA, ATP-dependent | 0.039 | Mouse | |
| CD86 | CD86 molecule | 0.038 | Rat | |
| NCSTN | nicastrin | 0.037 | ||
| PLEK | pleckstrin | 0.037 | ||
| IL2RG | interleukin 2 receptor, gamma | 0.036 | ||
| NOD2 | nucleotide-binding oligomerization domain containing 2 | 0.036 | ||
| GBA | glucosidase, beta, acid | 0.035 | ||
| RUNX1 | runt-related transcription factor 1 | 0.033 | ||
| BCL3 | B-cell CLL/lymphoma 3 | 0.033 | Mouse | |
| MSH3 | mutS homolog 3 (E. coli) | 0.030 | ||
| ICAM1 | intercellular adhesion molecule 1 | 0.029 | ||
| NCOR2 | nuclear receptor corepressor 2 | 0.028 | ||
| PML | promyelocytic leukemia | 0.028 | ||
| TNFRSF13B | tumor necrosis factor receptor superfamily, member 13B | 0.028 | ||
| MRE11A | MRE11 meiotic recombination 11 homolog A (S. cerevisiae) | 0.028 | ||
| CD1C | CD1c molecule | 0.026 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.026 | ||
| SIN3A | SIN3 homolog A, transcription regulator (yeast) | 0.026 | ||
| RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.026 | ||
| HDAC9 | histone deacetylase 9 | 0.026 | ||
| SOCS3 | suppressor of cytokine signaling 3 | 0.025 | ||
| RAB14 | RAB14, member RAS oncogene family | 0.025 | ||
| TNFAIP2 | tumor necrosis factor, alpha-induced protein 2 | 0.024 | ||
| PDZD11 | PDZ domain containing 11 | 0.024 | ||
| BRIP1 | BRCA1 interacting protein C-terminal helicase 1 | 0.023 | ||
| RAD50 | RAD50 homolog (S. cerevisiae) | 0.022 | ||
| TLN1 | talin 1 | 0.022 | ||
| CD33 | CD33 molecule | 0.022 | ||
| IL4 | interleukin 4 | 0.021 | Mouse | |
| RAC2 | ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) | 0.021 | ||
| TGFB1 | transforming growth factor, beta 1 | 0.021 | ||
| TYMP | thymidine phosphorylase | 0.021 | ||
| XRCC5 | X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining) | 0.021 | ||
| IL6R | interleukin 6 receptor | 0.021 | ||
| LAPTM5 | lysosomal protein transmembrane 5 | 0.020 | ||
| MICA | MHC class I polypeptide-related sequence A | 0.020 | ||
| PPARA | peroxisome proliferator-activated receptor alpha | 0.020 | ||
| EMP3 | epithelial membrane protein 3 | 0.018 | ||
| HCK | hemopoietic cell kinase | 0.018 | ||
| TRAF3 | TNF receptor-associated factor 3 | 0.018 | ||
| CCR2 | chemokine (C-C motif) receptor 2 | 0.017 | ||
| CD40 | CD40 molecule, TNF receptor superfamily member 5 | 0.017 | Mouse Rat | |
| LILRA2 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2 | 0.017 | ||
| PTAFR | platelet-activating factor receptor | 0.017 | ||
| FLNB | filamin B, beta | 0.017 | ||
| HK3 | hexokinase 3 (white cell) | 0.017 | ||
| SPI1 | spleen focus forming virus (SFFV) proviral integration oncogene spi1 | 0.017 | ||
| CTLA4 | cytotoxic T-lymphocyte-associated protein 4 | 0.016 | ||
| FRA10AC1 | fragile site, folic acid type, rare, fra(10)(q23.3) or fra(10)(q24.2) candidate 1 | 0.016 | ||
| CD1B | CD1b molecule | 0.016 | Human | |
| PMS2 | PMS2 postmeiotic segregation increased 2 (S. cerevisiae) | 0.016 | ||
| TICAM2 | toll-like receptor adaptor molecule 2 | 0.015 | ||
| LY96 | lymphocyte antigen 96 | 0.015 | ||
| TMSB10 | thymosin beta 10 | 0.015 | ||
| CCL22 | chemokine (C-C motif) ligand 22 | 0.015 | ||
| REL | v-rel reticuloendotheliosis viral oncogene homolog (avian) | 0.015 | ||
| LIN54 | lin-54 homolog (C. elegans) | 0.014 | ||
| CD80 | CD80 molecule | 0.014 | ||
| MSH2 | mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli) | 0.014 | Mouse | |
| CD1A | CD1a molecule | 0.014 | Human | |
| CCR7 | chemokine (C-C motif) receptor 7 | 0.014 | ||
| CASP1 | caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase) | 0.014 | ||
| TNFRSF1B | tumor necrosis factor receptor superfamily, member 1B | 0.013 | ||
| PLXND1 | plexin D1 | 0.013 | ||
| MLPH | melanophilin | 0.013 | ||
| CD1D | CD1d molecule | 0.013 | Human | |
| TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.013 | ||
| XRCC4 | X-ray repair complementing defective repair in Chinese hamster cells 4 | 0.013 | Mouse | |
| IRF4 | interferon regulatory factor 4 | 0.013 | Mouse | |
| PLAUR | plasminogen activator, urokinase receptor | 0.013 | ||
| SYK | spleen tyrosine kinase | 0.013 | ||
| SH3BP2 | SH3-domain binding protein 2 | 0.013 | ||
| IL21R | interleukin 21 receptor | 0.013 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.012 | ||
| CD44 | CD44 molecule (Indian blood group) | 0.012 | ||
| SFPQ | splicing factor proline/glutamine-rich | 0.012 | ||
| CCR1 | chemokine (C-C motif) receptor 1 | 0.012 | ||
| IRF8 | interferon regulatory factor 8 | 0.012 | ||
| PMS1 | PMS1 postmeiotic segregation increased 1 (S. cerevisiae) | 0.012 | ||
| ITGB7 | integrin, beta 7 | 0.012 | ||
| MAP3K8 | mitogen-activated protein kinase kinase kinase 8 | 0.011 | ||
| CLEC10A | C-type lectin domain family 10, member A | 0.011 | ||
| CYTH4 | cytohesin 4 | 0.011 | ||
| ZBTB16 | zinc finger and BTB domain containing 16 | 0.011 | ||
| ITGB1BP2 | integrin beta 1 binding protein (melusin) 2 | 0.011 | ||
| SIRPB1 | signal-regulatory protein beta 1 | 0.011 | ||
| DDIT3 | DNA-damage-inducible transcript 3 | 0.011 | ||
| MATK | megakaryocyte-associated tyrosine kinase | 0.011 | ||
| TANK | TRAF family member-associated NFKB activator | 0.011 | ||
| ZNF830 | zinc finger protein 830 | 0.011 | ||
| IL2RA | interleukin 2 receptor, alpha | 0.011 | ||
| FOSL2 | FOS-like antigen 2 | 0.011 | ||
| DTL | denticleless homolog (Drosophila) | 0.011 | ||
| TGFBR1 | transforming growth factor, beta receptor 1 | 0.011 | ||
| ASH2L | ash2 (absent, small, or homeotic)-like (Drosophila) | 0.010 | ||
| IL13RA1 | interleukin 13 receptor, alpha 1 | 0.010 | ||
| C1orf38 | chromosome 1 open reading frame 38 | 0.010 | ||
| NHEJ1 | nonhomologous end-joining factor 1 | 0.010 | ||
| IL7R | interleukin 7 receptor | 0.010 |